Azenta Inc at Morgan Stanley Global Healthcare Conference Transcript
All right. Well, thanks, everyone, for joining us today. It's Alberto Bertani from Morgan Stanley banking team. And it's my pleasure to host Lindon Robertson, CFO of Azenta; and Matt McManus, Chief Operating Officer. Thank you very much.
For important disclosures, please see Morgan Stanley Research Disclosure website at morganstanleyresearchdisclosures.com (sic) [morganstanley.com/researchdisclosures]. If you have any questions, please reach out to your Morgan Stanley sales representative.
So in terms of kicking off the discussion, can you give us sort of 10 minutes overview of the strategy of Azenta history as a life science company? That would be helpful.
Yes, that would be great. So we're in our first year as a life science company, but in about our 40th year as being a company. And so we've gone through a transition -- transformation out of 2021 as we separated a company that was born in the semiconductor space and we launched as a new life
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |